My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

8.060 +0.500 (+6.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,335,425
Open 7.580
Bid (Size) 7.720 (1)
Ask (Size) 8.050 (30)
Prev. Close 7.560
Today's Range 7.580 - 8.120
52wk Range 3.760 - 27.41
Shares Outstanding 93,100,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look Back at Therapeutics Stocks’ Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Pack
Looking back on therapeutics stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Myriad Genetics (NASDAQ:MYGN) and its peers. 
Via StockStory
Topics Artificial Intelligence
3 Unprofitable Stocks That Fall Short
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory

Performance

YTD
-40.3%
-40.3%
1 Month
+16.8%
+16.8%
3 Month
+43.9%
+43.9%
6 Month
-4.2%
-4.2%
1 Year
-70.1%
-70.1%

More News

Read More
3 Small-Cap Stocks That Concern Us
Via StockStory
Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way
Via StockStory
Topics Artificial Intelligence
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
From Myriad Genetics, Inc.
Via GlobeNewswire
1 Momentum Stock for Long-Term Investors and 2 Facing Challenges
Via StockStory
3 Russell 2000 Stocks with Open Questions
Via StockStory
Topics Regulatory Compliance
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
From Myriad Genetics, Inc.
Via GlobeNewswire
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
From Myriad Genetics, Inc.
Via GlobeNewswire
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
From Myriad Genetics, Inc.
Via GlobeNewswire
3 Stocks Under $10 We Approach with Caution
Via StockStory
Opendoor, SmartRent, Myriad Genetics, Reddit, and Unity Stocks Trade Down, What You Need To Know
Via StockStory
Topics Artificial Intelligence Economy World Trade
ANGLE Announces Collaboration with Myriad Genetics
Via ACCESS Newswire
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
From Myriad Genetics, Inc.
Via GlobeNewswire
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
Topics Stocks
New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results
From Myriad Genetics, Inc.
Via GlobeNewswire
MYGN Q2 Deep Dive: Oncology Strategy Shift and Product Execution Shape Guidance
Via StockStory
Topics Artificial Intelligence
What's going on in today's session
Via Chartmill
Why Is Myriad Genetics (MYGN) Stock Soaring Today
Via StockStory
Topics Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Here are the top movers in Wednesday's session.
Via Chartmill
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
Discover the top movers in Wednesday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 8.060
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 10/03/25 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 750.39M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 750M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.